Frankston turned on the weather at the 19th ASPREE study update this year. Participants and guests living in south east Melbourne and the Mornington Peninsula met at the Monash University Peninsula Campus for a very informative session and afternoon tea. Thanks to our guests for such a great day.
This packed edition, which has been posted to ASPREE participants, answers frequently asked questions about aspirin stories in the media, study medication, the Healthy Ageing Biobank, study visits and what to do with damaged study medication. We give a round up of Australian ASPREE participant locations, study updates and the newest edition to the ASPREE-RetCam Fleet.…Details
Wonderful to meet so many ASPREE participants and guests in Gippsland this month. We kicked off at the Traralgon Tennis Association rooms on 3rd December followed by a second presentation in Bairnsdale on 4th December. ASPREE Executive Officer, Assoc/Professor Robyn Woods gave the presentations, accompanied by Dr Carlene Britt, ASPREE’s Regional Manager. Local ASPREE study co-ordinators…Details
A letter from Principal Investigator, Prof John McNeil to 16,500 Australian ASPREE Participants and their GPs
To our ASPREE participants and co-investigating GPs, The ASPREE team sincerely thanks you for supporting the ASPREE study. Without your ongoing support for medical research, this significant trial would not be possible. For the next 3 years, ASPREE will be in the ‘observational’ stage until the trial concludes at the end of 2017. This 3 year…Details
PRESS RELEASE: Melbourne, December 1, 2014 – Australia’s largest clinical trial is a step closer to revealing in 2018 whether healthy older people should or should not take aspirin to prevent or delay cardiovascular disease (heart attack and stroke), dementia, depression and some types of cancers. ASPREE (ASPirin in Reducing Events in the Elderly), a…Details
ASPREE Chief Investigator in Tasmania, Professor Mark Nelson gives a great interview on ABC Radio National’s Health Report about aspirin and primary prevention. He discusses the JPPP (Japanese Primary Prevention Projection) and the ASPREE trial. To listen to the interview click here. Read the transcript here.
University of Adelaide’s Professor Nigel Stocks, chief investigator to the ASPREE study in South Australia, today welcomes participants and their guests at a study update in Marion. This is the first of two scheduled events for our Adelaide participants. Invitations to the second study update, which will be held in Salisbury, will be in the post in…Details
Bright red Proteus flowers adorned ASPREE Melbourne Manager, Dr Suzanne Orchard’s desk following her presentation to the Montrose and District Probus Club recently. So beautiful we had to tweet them, the flowers were a gift to Suzanne in appreciation for her presentation on aspirin and the ASPREE study. The pleasure is ours. We have been fortunate…Details
PRESS RELEASE: Melbourne, 20 October 2014: The use of aspirin to prevent cancer will be discussed by experts at a symposium in Melbourne today. Leading healthcare professionals will discuss the scientific evidence for and against the use of aspirin for the chemoprevention of cancer. With the rising importance of disease prevention, researchers are looking at…Details
Ballarat may have forgotten it was spring, but it didn’t put a dampener on meeting local ASPREE participants and guests at the study update today. We all braved the inclement weather – sun, sun, rain, downpour, FREEZING! (all in the space of a few hours) and look forward to the stories about the event on local Win News…Details